Calreticulin Mutations in Myeloproliferative Neoplasms
With the discovery of the JAK2V617F mutation in patients with Philadelphia chromosome-negative (Ph−) myeloproliferative neoplasms (MPNs) in 2005, major advances have been made in the diagnosis of MPNs, in understanding of their pathogenesis involving the JAK/STAT pathway, and finally in the developm...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Rambam Health Care Campus
2014-10-01
|
Series: | Rambam Maimonides Medical Journal |
Subjects: | |
Online Access: | http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=432 |